Long-term safety of long-acting octreotide in patients with diabetic retinopathy: results of pooled data from 2 randomized, double-blind, placebo-controlled phase 3 studies
Crossref DOI link: https://doi.org/10.1007/s12020-017-1448-5
Published Online: 2017-11-07
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Pivonello, Rosario
Muscogiuri, Giovanna
Holder, Geoffrey
Paul, Michaela
Sarp, Severine
Lesogor, Anastasia
Jordaan, Pierre
Eisinger, Johannes
Colao, Annamaria
Funding for this research was provided by:
Novartis Pharmaceuticals Corporation
License valid from 2017-11-07